Today, the President and COO ResMed Inc. of Resmed Inc (RMD), Robert Andrew Douglas, bought shares of RMD for $144.3K.
Following Robert Andrew Douglas’ last RMD Buy transaction on January 05, 2016, the stock climbed by 54.3%. This recent transaction increases Robert Andrew Douglas’ holding in the company by 5.93% to a total of $17.19 million.
See today’s analyst top recommended stocks >>
Based on Resmed Inc’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $588 million and quarterly net profit of $106 million. In comparison, last year the company earned revenue of $524 million and had a net profit of $86.13 million. RMD’s market cap is $14.85B and the company has a P/E ratio of 44.91. Currently, Resmed Inc has an average volume of 995.7K.
Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $94.50, reflecting a -9.2% downside.
In the last 30 days, insiders have sold $435.3K worth of RMD shares and purchased $144.3K worth of RMD shares.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
